Lactamase β reprograms lipid metabolism to inhibit the progression of endometrial cancer through attenuating MDM2-mediated p53 ubiquitination and degradation
Authors:
- 31 December 2024
- journal article
- research article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 764, 110287
Abstract
No abstract availableKeywords
Funding Information
- Medical and Health Science and Technology Development Project of Shandong Province (202005011525)
This publication has 39 references indexed in Scilit:
- PCBP1 protects bladder cancer cells from mitochondria injury and ferroptosis by inducing LACTB mRNA degradationMolecular Carcinogenesis, 2023
- LACTB induces cancer cell death through the activation of the intrinsic caspase-independent pathway in breast cancerApoptosis, 2022
- LACTB suppresses migration and invasion of glioblastoma via downregulating RHOC/Cofilin signaling pathwayBiochemical and Biophysical Research Communications, 2022
- p53 regulates lipid metabolism in cancerInternational Journal of Biological Macromolecules, 2021
- LACTB suppresses melanoma progression by attenuating PP1A and YAP interactionCancer Letters, 2021
- Annual report to the nation on the status of cancer, part I: National cancer statisticsCancer, 2020
- Lipid metabolism and lipophagy in cancerBiochemical and Biophysical Research Communications, 2018
- Transcription factors that interact with p53 and Mdm2International Journal of Cancer, 2015
- Expression and purification of the mitochondrial serine protease LACTB as an N-terminal GST fusion protein in Escherichia coliProtein Expression and Purification, 2005
- Identification, Genomic Organization, and mRNA Expression of LACTB, Encoding a Serine β-Lactamase-like Protein with an Amino-terminal Transmembrane DomainGenomics, 2001